Physician profile
Katelyn R Keefe
NPI 1073247045
$711.29
in general payments reported to CMS, 2019-2025
14 companies · $643 in 2025
The $643 reported for 2025 was more than what 91% of School (Registered Nurse) providers received nationally (typical 2025 total: $120).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $68.22 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $230.13 | 2023-2025 | |
| Lilly USA, LLC | $84.05 | 2025 | Jardiance |
| Abbvie INC. | $72.54 | 2025 | |
| Exact Sciences Corporation | $48.58 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Inspire Medical Systems, INC. | $44.34 | 2025 | Inspire |
| Vanda Pharmaceuticals INC. | $38.69 | 2025 | Fanapt |
| Pfizer INC. | $35.16 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.29 | 2025 | Jardiance |
| Heartflow, INC. | $27.70 | 2025 | |
| Lundbeck LLC | $24.70 | 2023 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $23.10 | 2025 | Rexulti |
| Ardelyx, INC. | $19.44 | 2025 | Ibsrela |
| Seqirus USA INC | $19.41 | 2025 | Flucelvax, Fluad |
| Astrazeneca Pharmaceuticals Lp | $15.16 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Keefe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.